Phage-Derived Peptidoglycan Degrading Enzymes: Challenges and Future Prospects for In Vivo Therapy is a research paper published in Viruses (2018). On theSindex it has a DataRank of 5.3. It has been cited 166 times, with 162 citing works in its 1-hop citation network.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.768
From this paper's citation signal
Citation Network Contribution
4.5
From 136 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 162 citers.
Fundação para a Ciência e a Tecnologia, I.P.
Grant: PTDC/BBB-BSS/6471/2014
SynPhage-Construction of synthetic phages to combat infectious bacterial diseases
Fundação para a Ciência e a Tecnologia, I.P.
Grant: UID/BIO/04469/2013
Centre of Biological Engineering - University of Minho
Fundação para a Ciência e a Tecnologia, I.P.
Grant: SFRH/BPD/111653/2015
Targeting A. baumannii infectious biofilms with a multivalent phage-based enzyme cocktail
FWCI
8.87
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals